rhinosinus
extrem
common
nation
survey
adult
report
diagnos
rhinosinus
previou
month
estim
preval
chronic
rhinosinus
usa
rang
women
disproport
affect
compar
men
acut
chronic
rhinosinus
preval
middleag
adult
compar
age
group
primari
care
physician
specialist
manag
rhinosinus
equival
technic
effici
primari
care
physician
provid
less
costli
treatment
chronic
rhinosinus
high
econom
burden
total
expenditur
unit
state
estim
billion
rhinosinus
common
patient
comorbid
asthma
allerg
rhiniti
predispos
factor
list
tabl
studi
investig
relationship
smoke
rhinosinus
conflict
vast
major
case
acut
rhinosinus
viral
etiolog
incid
high
averag
adult
affect
estim
time
per
year
secondari
bacteri
infect
uncommon
complic
case
two
common
bacteri
caus
rhinosinus
streptococcu
pneumonia
haemophilu
influenza
less
common
pathogen
includ
moraxella
catarrhali
streptococcu
pyogen
staphylococcu
aureu
classic
clinic
present
rhinosinus
includ
nasal
congest
mucopurul
nasal
discharg
facial
pain
pressur
fever
associ
symptom
includ
anosmia
hyposmia
aural
full
cough
headach
toothach
diagnosi
bacteri
rhinosinus
clinic
previou
studi
use
criteria
base
symptom
tabl
diagnosi
rhinosinus
requir
presenc
least
two
major
criteria
one
major
plu
two
minor
criteria
diagnos
made
criteria
correl
radiograph
evid
sinu
involv
distinguish
bacteri
viral
etiolog
reason
infecti
diseas
societi
america
idsa
adopt
guidelin
base
characterist
pattern
take
account
durat
sever
tempor
progress
doubl
sicken
differenti
bacteri
viral
rhinosinus
diagnosi
bacteri
rhinosinus
requir
three
follow
clinic
present
persist
symptom
sign
compat
acut
rhinosinus
last
least
day
without
improv
b
sever
symptom
either
fever
least
purul
nasal
discharg
facial
pain
last
least
consecut
day
onset
ill
c
worsen
symptom
sign
includ
new
onset
fever
headach
increas
nasal
discharg
initi
improv
day
follow
upper
respiratori
infect
idsa
guidelin
mention
previous
cornerston
diagnosi
follow
physic
exam
find
support
suspect
diagnosi
bacteri
rhinosinus
purul
nasal
discharg
nasal
obstruct
sinu
tender
nasal
mucos
erythema
edema
andor
infraorbit
venou
pool
valid
studi
examin
predict
valu
specif
sign
like
associ
bacteri
rather
viral
etiolog
antibiot
therapi
initi
clinic
diagnosi
bacteri
rhinosinus
establish
idsa
criteria
previous
describ
antibiot
initi
set
shorten
durat
ill
offer
prompt
symptomat
relief
prevent
recurr
suppur
complic
standarddos
amoxicillinclavulan
mg
twice
daili
rather
amoxicillin
alon
recommend
firstlin
treatment
due
high
preval
h
influenza
howev
standarddos
amoxicillinclavulan
inadequ
penicillinnonsuscept
pn
pneumonia
mutat
penicillinbind
protein
unaffect
addit
inhibitor
thu
patient
certain
risk
factor
highdos
amoxicillinclavulan
ie
mg
twice
daili
recommend
firstlin
treatment
risk
factor
pn
includ
resid
geograph
region
high
endem
rate
pn
pneumonia
sever
infect
eg
sign
system
toxic
fever
age
year
recent
hospit
patient
immunocompromis
antibiot
use
within
past
month
respiratori
fluoroquinolon
also
highli
activ
pn
pneumonia
h
influenza
superior
antibiot
option
patient
antibiot
allergi
includ
doxycyclin
mg
twice
daili
mg
daili
levofloxacin
mg
daili
moxifloxacin
mg
daili
symptomat
manag
may
includ
analges
antipyret
intranas
glucocorticoid
hydrat
possibl
nasal
salin
irrig
intranas
glucocorticoid
help
reduc
reliev
symptom
compar
placebo
use
monotherapi
adjunct
antibiot
higher
dose
stronger
effect
reliev
symptom
without
signific
increas
advers
effect
benefit
nasal
salin
irrig
unclear
rel
safe
may
reduc
time
work
minor
advers
effect
dri
nose
irrit
experienc
fewer
half
user
optim
concentr
frequenc
volum
techniqu
irrig
determin
littl
evid
topic
oral
decongest
provid
benefit
adjunct
treatment
antibiot
base
symptom
score
histolog
chang
radiograph
find
howev
patient
report
symptomat
improv
decongest
may
consid
patient
viral
rhinosinus
antibiot
therapi
indic
topic
decongest
use
caution
howev
sinc
trigger
rebound
congest
inflamm
especi
use
day
also
scant
evid
antihistamin
provid
signific
relief
patient
rhinosinus
may
benefici
patient
concomit
allerg
rhiniti
firstgener
antihistamin
avoid
elderli
suscept
anticholinerg
effect
decongest
antihistamin
avoid
children
year
age
use
medic
may
increas
morbid
small
number
death
popul
report
mucolyt
thin
mucu
improv
nasal
drainag
evid
support
effect
rhinosinus
system
steroid
leukotrien
inhibitor
may
consid
chronic
rhinosinus
especi
patient
nasal
polyp
lack
consensu
treatment
chronic
rhinosinus
like
due
inher
heterogen
therefor
referr
otolaryngologist
warrant
case
acut
rhinosinus
improv
maxim
medic
therapi
recurr
infect
defin
episod
per
year
case
predispos
medic
condit
immunodefici
allerg
diseas
diabet
mellitu
immotil
cilia
syndrom
consid
surgeri
reserv
patient
chronic
rhinosinus
fail
maxim
medic
therapi
typic
defin
therapi
week
underli
anatom
abnorm
well
clear
demonstr
rhinosinus
ct
imag
endoscop
examin
adult
patient
experi
symptomat
improv
surgeri
surgic
intervent
rare
indic
children
tonsillopharyng
among
common
reason
primari
care
visit
account
visit
children
famili
physician
pediatrician
throatrel
symptom
common
reason
physician
visit
common
reason
emerg
room
visit
estim
econom
burden
group
streptococc
tonsillopharyng
specif
estim
million
annual
children
miss
averag
day
school
parent
miss
day
work
order
care
common
caus
tonsillopharyng
viral
infect
common
virus
includ
rhinoviru
coronaviru
adenoviru
parainfluenza
influenza
echoviru
reoviru
respiratori
syncyti
viru
herp
simplex
viru
coxsackieviru
epsteinbarr
viru
bacteri
caus
includ
streptococci
corynebacterium
diphtheria
neisseria
gonorrhoea
chlamydia
pneumonia
mycoplasma
pneumonia
group
streptococcu
ga
common
bacteri
caus
thrush
commonli
caus
candida
speci
also
caus
sore
throat
inflammatori
caus
tonsillopharyng
includ
laryngopharyng
reflux
allerg
rhiniti
postnas
drip
foreign
bodi
chronic
mouth
breath
mucos
muscl
tension
dysphonia
vocal
cord
granuloma
rheumatoid
arthriti
gout
pemphigu
kawasaki
diseas
characterist
present
ga
tonsillopharyng
includ
abrupt
onset
sore
throat
odynophagia
fever
headach
abdomin
pain
nausea
vomit
physic
exam
find
may
includ
tonsillopharyng
erythema
exud
beefyr
swollen
uvula
soft
palat
petechia
anterior
cervic
lymphadenopathi
scarlatiniform
rash
peritonsillar
abscess
commonli
seen
patient
age
recurr
chronic
tonsillopharyng
inadequ
treat
abscess
develop
space
later
aspect
tonsil
pharyng
constrictor
muscl
peritonsillar
abscess
difficult
distinguish
sever
tonsillopharyng
present
asymmetr
tonsillar
hypertrophi
drool
hallmark
peritonsillar
abscess
howev
trismu
result
inflamm
pu
track
pterygoid
region
characterist
symptom
includ
muffl
hot
potato
voic
sever
unilater
sore
throat
edema
ipsilater
soft
palat
deviat
uvula
diagnosi
question
ultrasonographi
transcutan
intraor
ct
imag
aid
identifi
abscess
thu
distinguish
peritonsillar
cellul
concern
spread
infect
later
neck
contrast
imag
mri
ct
indic
retropharyng
abscess
affect
younger
children
typic
year
age
characterist
present
includ
neck
stiff
dysphagia
odynophagia
high
fever
follow
upper
respiratori
infect
airway
affect
depend
degre
obstruct
manifest
muffl
voic
drool
trismu
stridor
tachypnea
tripod
posit
may
extern
neck
swell
immedi
consult
otolaryngologist
anesthesiologist
warrant
given
potenti
lifethreaten
airway
compromis
patient
stabl
imag
obtain
ct
neck
contrast
modal
choic
suppur
complic
ga
tonsillopharyng
includ
cervic
lymphaden
sinus
otiti
media
mastoid
nonsuppur
complic
ga
tonsillopharyng
postinfecti
immunolog
mediat
includ
acut
rheumat
fever
acut
poststreptococc
glomerulonephr
poststreptococc
reactiv
arthriti
patient
uncompl
ga
tonsillopharyng
treat
antibiot
therapi
treatment
accomplish
three
object
prevent
suppur
complic
acut
rheumat
fever
decreas
communic
allow
patient
return
work
school
shorten
durat
ill
firstlin
treatment
option
penicillin
mg
twice
three
time
daili
children
mg
four
time
daili
mg
twice
daili
adolesc
adult
amoxicillin
mgkg
daili
maximum
dose
mgday
day
penicillinallerg
patient
may
treat
firstgener
cephalosporin
cephalexin
mgkgdose
twice
daili
maximum
mgdose
cefadroxil
mgkg
daili
maximum
mgday
day
clindamycin
mgkgdose
twice
daili
maximum
mgdose
day
azithromycin
mgkg
daili
maximum
mgday
day
evid
one
antibiot
superior
anoth
adjunct
treatment
acetaminophen
nonsteroid
antiinflammatori
agent
use
control
fever
pain
complementari
therapi
includ
acupunctur
herbal
dietari
supplement
shown
benefici
treatment
peritonsillar
abscess
includ
hydrat
incis
drainag
local
anesthesia
antibiot
aim
aerob
anaerob
bacteria
tonsillectomi
indic
incis
drainag
fail
complet
drain
abscess
treatment
retropharyng
abscess
involv
immedi
intraven
antibiot
therapi
aim
gramposit
aerob
anaerob
small
cm
retropharyng
abscess
often
treat
antibiot
alon
patient
fail
improv
hour
therapi
incis
drainag
indic
chronic
carrier
ga
present
pharynx
immunolog
respons
organ
temper
climat
winter
spring
month
mani
schoolag
children
asymptomat
carrier
antimicrobi
therapi
gener
indic
patient
like
contagi
develop
suppur
nonsuppur
complic
howev
certain
indic
erad
ga
carriag
consid
commun
outbreak
acut
rheumat
fever
context
poststreptococc
glomerulonephr
invas
ga
infect
outbreak
ga
tonsillopharyng
close
partial
close
commun
presenc
person
famili
histori
acut
rheumat
fever
famili
signific
anxieti
ga
infect
tonsillectomi
consider
sole
carriag
sever
explan
patient
recurr
episod
ga
tonsillopharyng
repeat
viral
infect
chronic
ga
carrier
noncompli
antibiot
therapi
new
infect
acquir
close
contact
test
cure
indic
antibiot
failur
rare
taken
prescrib
pingpong
infect
within
famili
suspect
simultan
obtain
radt
cultur
member
treat
posit
reason
asymptomat
contact
treat
antibiot
prophylaxi
household
contact
penicillin
shown
decreas
incid
develop
subsequ
ga
tonsillopharyng
tonsillectomi
one
common
procedur
perform
unit
state
carri
children
younger
year
age
year
american
academi
otolaryngolog
recommend
tonsillectomi
children
episod
tonsillopharyng
past
year
episod
per
year
past
year
episod
per
year
past
year
tonsillectomi
shown
improv
qualiti
life
children
recurr
tonsillopharyng
reduc
number
throat
infect
healthcar
provid
visit
need
antibiot
therapi
children
sever
frequent
episod
tonsillopharyng
may
benefit
tonsillectomi
less
sever
affect
children
tonsillectomi
may
also
benefici
patient
multipl
antibiot
allergi
pfapa
syndrom
period
fever
aphthou
stomat
pharyng
aden
recurr
peritonsillar
abscess
limit
evid
effect
tonsillectomi
adult
recurr
tonsillopharyng
retrospect
data
posit
prolong
effect
qualiti
life
especi
regard
younger
patient
sever
symptom
